These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9083058)

  • 21. Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding.
    Schreuder M; Reitsma PH; Bos MHA
    J Thromb Haemost; 2019 Aug; 17(8):1229-1239. PubMed ID: 31102425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralization.
    Spencer FA; Ball SP; Zhang Q; Liu L; Benoit S; Becker RC
    J Thromb Thrombolysis; 2000 Apr; 9(3):223-8. PubMed ID: 10728020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential receptor cascade for coagulation proteins on monocytes. Constitutive biosynthesis and functional prothrombinase activity of a membrane form of factor V/Va.
    Altieri DC; Edgington TS
    J Biol Chem; 1989 Feb; 264(5):2969-72. PubMed ID: 2536728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prothrombin contributes to the assembly of the factor Va-factor Xa complex at phosphatidylserine-containing phospholipid membranes.
    Billy D; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 1995 Nov; 270(45):26883-9. PubMed ID: 7592932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal formation of the prothrombinase complex: factor V deficiency and related disorders.
    Tracy PB; Mann KG
    Hum Pathol; 1987 Feb; 18(2):162-9. PubMed ID: 3804320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into the spatiotemporal localization of prothrombinase in vivo.
    Ivanciu L; Krishnaswamy S; Camire RM
    Blood; 2014 Sep; 124(11):1705-14. PubMed ID: 24869936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation-dependent exposure of the inter-EGF sequence Leu83-Leu88 in factor Xa mediates ligand binding to effector cell protease receptor-1.
    Ambrosini G; Plescia J; Chu KC; High KA; Altieri DC
    J Biol Chem; 1997 Mar; 272(13):8340-5. PubMed ID: 9079657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-derived microparticles express high affinity receptors for factor VIII.
    Gilbert GE; Sims PJ; Wiedmer T; Furie B; Furie BC; Shattil SJ
    J Biol Chem; 1991 Sep; 266(26):17261-8. PubMed ID: 1654328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
    Huang X; Swanson R; Kroh HK; Bock PE
    J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteolytic alterations of factor Va bound to platelets.
    Tracy PB; Nesheim ME; Mann KG
    J Biol Chem; 1983 Jan; 258(1):662-9. PubMed ID: 6848522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor X.
    Kalafatis M; Beck DO
    Biochemistry; 2002 Oct; 41(42):12715-28. PubMed ID: 12379114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of platelets upon factor Xa-catalyzed activation of factor VII in vitro.
    Rao LV; Rapaport SI
    Blood; 1988 Aug; 72(2):396-401. PubMed ID: 3135857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
    Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
    Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of the heavy and light chains of factor Va to the interaction with factor Xa.
    Kalafatis M; Xue J; Lawler CM; Mann KG
    Biochemistry; 1994 May; 33(21):6538-45. PubMed ID: 8204589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coordinate binding of factor Va and factor Xa to the unstimulated platelet.
    Tracy PB; Nesheim ME; Mann KG
    J Biol Chem; 1981 Jan; 256(2):743-51. PubMed ID: 7451472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperative regulation of the activity of factor Xa within prothrombinase by discrete amino acid regions from factor Va heavy chain.
    Barhoover MA; Orban T; Bukys MA; Kalafatis M
    Biochemistry; 2008 Dec; 47(48):12835-43. PubMed ID: 18991406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase.
    Mast AE; Broze GJ
    Blood; 1996 Mar; 87(5):1845-50. PubMed ID: 8634431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.
    Nesheim ME; Taswell JB; Mann KG
    J Biol Chem; 1979 Nov; 254(21):10952-62. PubMed ID: 500617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.